MicroPort's implantable implantable defibrillator and pacemaker spinoff has secured funding in a series C round co-led by its parent company.

China-headquartered medical device maker MicroPort Scientific Corporation has invested $47m to co-lead a $150m series C round for France-based pacemaker and defibrillator spinoff MicroPort Cardiac Rhythm Management (CRM). Hedge fund manager Hillhouse Capital Group co-led the round with $26m, and the rest came from property developer Country Garden’s investment arm, Country Garden Venture Capital, as…

The rest of this content is only accessible to Corporate Venturing: News, Data, and Events - Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.